Outcome After CR
| Outcome at 4 yrs . | Overall . | WBC <10 × 109/L . | WBC >10 × 109/L . | |||
|---|---|---|---|---|---|---|
| Short . | Extended . | Short . | Extended . | Short . | Extended . | |
| Death in CR (%) | 8 | 8 (P = 1.0) | 8 | 8 (P = .9) | 9 | 0 (P = .8) |
| Relapse risk (%) | 36 | 20 (P = .04) | 35 | 13 (P = .04) | 36 | 47 (P = .5) |
| DFS (%) | 59 | 72 (P = .07) | 59 | 77 (P = .02) | 58 | 53 (P = .6) |
| Survival from relapse at 2 yrs (%) | 44 | 43 (P = .5) | Numbers too small | |||
| OS (%) | 52 | 71 (P = .005) | 57 | 80 (P = .0009) | 43 | 43 (P = .6) |
| Outcome at 4 yrs . | Overall . | WBC <10 × 109/L . | WBC >10 × 109/L . | |||
|---|---|---|---|---|---|---|
| Short . | Extended . | Short . | Extended . | Short . | Extended . | |
| Death in CR (%) | 8 | 8 (P = 1.0) | 8 | 8 (P = .9) | 9 | 0 (P = .8) |
| Relapse risk (%) | 36 | 20 (P = .04) | 35 | 13 (P = .04) | 36 | 47 (P = .5) |
| DFS (%) | 59 | 72 (P = .07) | 59 | 77 (P = .02) | 58 | 53 (P = .6) |
| Survival from relapse at 2 yrs (%) | 44 | 43 (P = .5) | Numbers too small | |||
| OS (%) | 52 | 71 (P = .005) | 57 | 80 (P = .0009) | 43 | 43 (P = .6) |